MT Newswires
Halozyme Therapeutics, Takeda Collaborate on Vedolizumab Drug Delivery
📈
AI Sentiment
Highly Positive
8/10
Halozyme Therapeutics Inc. News
Latest updates and market news for HALO
7 news
Jan 6 - Jan 12, 2026
Page 1
Zacks
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
📊
AI Sentiment
Positive
6/10
PR Newswire
Halozyme Announces Global Collaboration and License Agreement with Takeda to Develop and Commercialize Vedolizumab with ENHANZE®
📈
AI Sentiment
Highly Positive
9/10
StockStory
Halozyme Therapeutics (HALO): Buy, Sell, or Hold Post Q3 Earnings?
📈
AI Sentiment
Highly Positive
9/10
Investor's Business Daily
Smorgasbord Of Buy Points Kicks Off 2026. Google, Nvidia On The Menu.
📊
AI Sentiment
Positive
6/10
Simply Wall St.
A Look At Halozyme Therapeutics (HALO) Valuation After New ENHANZE Obesity Partnership With Skye Bioscience
📈
AI Sentiment
Highly Positive
8/10
Share this news page